Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News First Wave BioPharma Inc FWBI

Healthcare Biotechnology
First Wave BioPharma, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal (GI) diseases. It is focused on developing a therapeutic pipeline with multiple late-stage clinical programs built around four proprietary technologies: Latiglutenase, a targeted... see more

Recent & Breaking News (NDAQ:FWBI)

First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase

GlobeNewswire 1 day ago

First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference

GlobeNewswire 3 days ago

First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference

GlobeNewswire March 18, 2024

First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline

GlobeNewswire March 14, 2024

First Wave BioPharma to Participate In 'Fireside Chat' at the 36th Annual Roth Conference

GlobeNewswire March 5, 2024

First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering

GlobeNewswire March 4, 2024

First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024

GlobeNewswire February 13, 2024

First Wave BioPharma to Present at the DealFlow MicroCap Conference

GlobeNewswire January 23, 2024

First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico

GlobeNewswire January 17, 2024

First Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024

GlobeNewswire January 4, 2024

First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.8 Million Gross Proceeds Priced

GlobeNewswire December 27, 2023

First Wave BioPharma Announces Streamlining of Clinical Pipeline with Non-Binding Term Sheet to Sell Niclosamide IBD Program

GlobeNewswire December 27, 2023

First Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical Company

GlobeNewswire December 18, 2023

First Wave BioPharma Announces 1-for-20 Reverse Stock Split and Results of the Special Meeting of Stockholders

GlobeNewswire December 14, 2023

First Wave BioPharma to Participate in BIO Partnering @JPM During "J.P. Morgan Week 2024" 

GlobeNewswire December 6, 2023

First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Conference

GlobeNewswire December 5, 2023

Date and Time Announced for First Wave BioPharma CEO James Sapirstein's Presentation at the 2023 BIO Investor Forum

GlobeNewswire October 10, 2023

First Wave BioPharma CEO James Sapirstein to Present at the 2023 Roth Healthcare Opportunities Conference

GlobeNewswire October 3, 2023

First Wave BioPharma To Present at the BIO Investor Forum

GlobeNewswire September 15, 2023

First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.0 Million Gross Proceeds Priced At-the-Market

GlobeNewswire September 14, 2023